Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:RE:RE:RE:RE:RE:RE:April 8 interview with Dan Legault

[bringon10bagger]

qwerty, I disapprove of the statement of FDA approvals still being a high risk, once we see the results of this 2b phase, and results are equally or better pain relief than Naproxen at x2-x4 the dose, IMO ATE will get the nod that we are "Best in Class", GI Safe, and this does not satisfy being high risk,.as we know there's a rsik in any stock play. Make no mistake Dan and team have all bases covered off with tons of brain power all working to get this to fruition. Cheers!...

qwerty22 wrote:

A bit of perspective friend. I'm optimistically hoping for a market cap of $300mln (roughly the analysts targets) by the Fall, our friend Ming-the-limitless has a nailed down value just for 346 of $30/share (+$10bln). I'm afraid he's a fantasists. He doesn't have any concept of real world processes. As others have pointed out the risk of failure to get approved is still high, the uncertainty in the revenue modelling is real, the big pharma partner is going to want a big slice of the pie, he doesn't even seem to consider the concept of time passing (those peak revenues are at least 6 years away). All these things (and more) affect valuation but he's got all that  value nailed down with a simple calculation 30% of $20bln.

The same is true of the covid stuff. Legault effectively said they are parcelling up some drug to send it to N American scientists to play with it in the lab viral models. Ming-the-limitless reads that and sees "it's being tested on covid". It's not, that is a lie/fantasy. Listen to Legault in the long video he's careful to only talk about new stuff that he doesn't consider "material". If he's talking about anti-viral in these videos then he doesn't consider it material and I think we should stay in line with him. I hate to be a dream-killer but when it strays into outright bs then it needs calling out.

I don't want to spend too long analyzing Ming but what he seems to do is jump all the way to the end of the process and then somehow imagine that is where we are at point. He did it with covid, he's doing it with the valuation (he's not even doing a good job of describing the end point with that). There is a long, risky, uncertain path to the pot of gold, it's unrealistic and dangerous to spend all your time just focused on the prize. IMO

 

Stage-2 wrote: Sounds like you getting a bit excited mate seeing green in your account and at the same time not appreciating Ming’s excitement for the possibility of other things.  How about you sit down and shut up cause you sound like a broken rececececord